Skip to main content
Insights into Imaging

Table 1 Guidelines recommendations for the use of CTCA

From: The impact and challenges of implementing CTCA according to the 2019 ESC guidelines on chronic coronary syndromes: a survey and projection of CTCA services in the Netherlands

Recommendations 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

Class

Level

Risk stratification, preferably using stress imaging or CTCA (if permitted by local expertise and availability), or alternatively exercise stress ECG (if significant exercise can be performed and the ECG is amenable to the identification of ischaemic changes), is recommended in patients with suspected or newly diagnosed CAD

I

B

Non-invasive functional imaging for myocardial ischaemia or CTCA is recommended as the initial test to diagnose CAD in symptomatic patients in whom obstructive CAD cannot be excluded by clinical assessment alone

I

B

ICA or CTCA is recommended in patients with characteristic episodic resting angina and ST-segment changes, which resolve with nitrates and/or calcium antagonists, to determine the extent of underlying coronary disease

I

C

Coronary CTA should be considered as an alternative to coronary angiography before valve intervention in patients with severe valvular heart disease and low probability of CAD

IIa

C

  1. The mentioned ESC guideline recommendations are class I (recommended or indicated) and class IIa (should be considered). The level of evidence is: A, derived from multiple randomised clinical trials or meta-analyses, B, derived from a single randomised clinical trial or large non-randomised studies, C, is a consensus of opinion of the experts and/or small studies, retrospective studies, registries
Back to article page